Home
Live Updates
Octapharma USA Requests FDA Approval for wilate® VWD Prophylaxis Supplement : comparemela.com
Octapharma USA Requests FDA Approval for wilate® VWD Prophylaxis Supplement
/PRNewswire/ -- Octapharma USA has submitted a Biologics License Application Supplement (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the...
Related Keywords
Germany ,
United States ,
Lachen ,
Switzerland General ,
Switzerland ,
Sweden ,
Austria ,
France ,
Willebrand ,
Nordrhein Westfalen ,
American ,
Sigurd Knaub ,
Alit Taher ,
Claudia Khayat ,
Katerynav Vilchevska ,
Leonid Dubey ,
Sylvia Werner ,
Toshko Lissitchkov ,
Dzmitry Novik ,
Elina Peteva ,
Flemming Nielsen ,
Vladimir Vdovin ,
Adlette Inati ,
Margarita Arkadevna Timofeeva ,
Robertf Sidonio Jr ,
Centers For Disease ,
Aflac Cancer Blood Disorders Center ,
Octapharma Group ,
Emory University School Of Medicine ,
Drug Administration ,
Octapharma United States Inc ,
Biologics License Application Supplement ,
Coagulation Factor ,
Lyophilized Powder ,
Intravenous Injection ,
Octapharma United States President Flemming ,
Investigator Robert ,
Medical Director ,
Aflac Cancer ,
Blood Disorders Center ,
Associate Professor ,
Emory University School ,
Octapharma United States ,
Disease Control ,
Willebrand Disease ,
Ana Boban ,
Csongor Kiss ,
Plasma Derived Von Willebrand ,
Previously Treated Patients ,
Von Willebrand ,
Century Road ,
Octapharma Usa ,
comparemela.com © 2020. All Rights Reserved.